Ulip6, a novel unc-33 and dihydropyrimidinase related protein highly expressed in developing rat brain  by Horiuchi, Masahisa et al.
Ulip6, a novel unc-33 and dihydropyrimidinase related protein highly
expressed in developing rat brain
Masahisa Horiuchi, Oussama El Far, Heinrich Betz*
Department of Neurochemistry, Max-Planck-Institute for Brain Research, Deutschordenstrasse 46, D-60528 Frankfurt am Main, Germany
Received 30 June 2000; revised 8 August 2000; accepted 8 August 2000
Edited by Ned Mantei
Abstract Here, we report the identification of Ulip6, a novel
unc-33 and dihydropyrimidinase related protein that belongs to
the Ulip/CRMP protein family. Ulip6 was found in a yeast two-
hybrid screen using the neuronal glycine transporter GlyT2 as
bait. The rat and human Ulip6 sequences are highly homologous
and most closely related to the liver enzyme dihydropyrimidinase
(Ulip5). Northern and Western analysis of rat tissues revealed
that the distribution of the Ulip6 mRNA and protein resembles
those of brain-type Ulip proteins. Like Ulip1^4, Ulip6 is highly
expressed in embryonic and early postnatal brain and spinal
cord. These findings are consistent with Ulip6 having a function
in neuronal differentiation and/or axon growth. ß 2000 Feder-
ation of European Biochemical Societies. Published by Elsevier
Science B.V. All rights reserved.
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1. Introduction
The development of neuronal networks requires the out-
growth of axons from postmitotic neurons towards their tar-
get cells to allow the establishment of functional synaptic
connections. Axonal growth depends on a specialized subcel-
lular structure at the tip of the extending neurite, the neuronal
growth cone. Besides a highly specialized cytoskeleton, the
growth cone contains a number of plasma membrane proteins
and receptors that are involved in neurotransmitter metabo-
lism and recognition of extracellular guidance cues during the
process of axonal path¢nding. Among these are receptors for
attracting and repelling signaling molecules, such as the ne-
trins, collapsins/semaphorins and ephrins [1], as well as trans-
porters for neurotransmitters, like serotonin [2] and excitatory
and inhibitory amino acids [3,4]. All these membrane proteins
have been reported to be enriched in the growth cone and
may also be found in mature presynaptic terminals.
In an attempt to identify the intracellular machinery that
targets these membrane proteins to the axonal compartment,
we have employed a yeast two-hybrid screen with a transport-
er for the inhibitory amino acid glycine, the Na/Cl3 depen-
dent glycine transporter GlyT2. This transporter has been
demonstrated to be highly concentrated in the growth cone
of developing spinal neurons [3] and is characterized by a
unique N-terminal cytoplasmic domain of 201 amino acids
[5]. Unexpectedly, our screen with this domain identi¢ed a
novel gene product that belongs to a family of proteins which
have been implicated in the signaling cascades mediating axo-
nal guidance. In this report, we present the sequences of this
protein, termed Ulip6, from rat and human and show that it
is highly expressed in the embryonic and early postnatal rat
nervous system.
2. Materials and methods
2.1. Identi¢cation of rat and human Ulip6 cDNAs
Yeast two-hybrid screening was performed with the DupLEX-A1
yeast two-hybrid system on a cDNA library constructed from adult
rat brain in pJG4-5 (OriGene). As a bait, the N-terminal region of rat
GlyT2 (residues 1^201) [5] inserted into pGilda (OriGene) was used.
Screening of 2U107 clones resulted in the isolation of 48 blue colo-
nies. Out of these, seven clones harboring the same Ulip6 cDNA were
isolated. To identify the missing 5P region, we performed PCR on an
adult rat brain cDNA library (Clontech) cloned in the pGAD10 vec-
tor using the sequence 5P-CTTGGTCCCGTGGTAGAAGTCG-3P
corresponding to nucleotides 363^384 of the Ulip6 cDNA and the
adapter primer 5P-CTATTCGATGATGAAGATACCCCACCAA-
ACCC-3P complementary to the vector sequence. The resulting prod-
uct was re-ampli¢ed using a nested primer 5P-CAGTCATCGTTCAC-
CACCTTGCC-3P deduced from the Ulip6 cDNA (nucleotides 166^
188) and the adapter primer speci¢ed above. The ¢nal product was
cloned into the pCR 2.1-TOPO vector for sequencing (Invitrogen). All
DNA sequences were veri¢ed by dideoxy-sequencing of both strands.
To isolate the human Ulip6 cDNA, cDNA was synthesized from a
human spinal cord poly(A)RNA (Clontech) using a ¢rst-strand
cDNA synthesis kit (Pharmacia Biotech). This cDNA served then as
template for PCR ampli¢cation with the primers 5P-CGCAG-
CATCCTGGAGGAGAA-3P and 5P-GCAGCTTCGGCTGGAGAG-
TT-3P deduced from the human ESTs AI571188 and AI369696. These
ESTs were identi¢ed by BLAST search in the DDBJ web site and
correspond to the putative 5P and 3P untranslated regions of the hu-
man Ulip6 sequence.
The rat and human Ulip6 nucleotide sequences are deposited in the
EMBL/GenBank database under accession numbers AJ131436 and
AJ251275.
2.2. Northern analysis
RNA isolation from various rat tissues was performed using the
RNeasy kit (Qiagen). Total RNA (11 Wg per lane) was analyzed by
Northern blotting as described previously [6]. As hybridization
probes, both a 1.7 kb fragment ampli¢ed by PCR from the coding
sequence (nucleotides 127^1833) and a 3.0 kb PstI/XhoI fragment
corresponding to the 3P untranslated region (nucleotides 1895^4845)
of the rat Ulip6 cDNA were labelled with a randomly primed DNA
labelling kit (Boehringer Mannheim). A 1.1 kb fragment of the mouse
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA (Clon-
tech) was used as internal control. After hybridization, membranes
were washed twice with 0.1USSC and 0.1% (w/v) SDS at 60‡C for
20 min, and autoradiography was performed with Biomax1 MR X-
ray ¢lm (Kodak) at 380‡C for 7 days.
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2.3. Antibodies
Two peptides (peptide 1: KLVQREKTLKVRGVDRTPC; peptide
2: DTPTRPVTRHGGMRDLC) corresponding to positions 474^491
and 513^528, respectively, of rat and human Ulip6 were synthesized
(Fig. 1A) and conjugated to keyhole limpet hemocyanin to allow
immunization of rabbits (Biotrend). Polyclonal anti-Ulip6 sera were
collected over 2 months after several booster injections with both
antigens. A mouse monoclonal antibody (12CA5) against hemagglu-
tinin (HA) was purchased from Boehringer Mannheim.
2.4. Expression constructs
An HA epitope was inserted into the Ulip1^6 sequences after the
initiator methionine by using PCR with the following cDNAs as tem-
plates: mouse Ulip1^4 cDNAs, kindly provided by Dr. A. Sobel,
Paris, France; rat Ulip5 (dihydropyrimidinase), donated by Drs. K.
Matsuda and N. Tamaki, Kobe, Japan; and rat Ulip6 isolated here.
The products were subcloned into the eukaryotic expression vector
pBK-CMVvlac (Stratagene) [7] for use in transfection experiments.
2.5. Recombinant expression of Ulip proteins in HEK 293 cells and
Western blotting
The culture conditions for human embryonic kidney 293 (HEK
293) cells (ATCC#CRL-1573) and the protocols used for transfections
have been described in detail [8]. For the detection of the di¡erent
Ulip proteins in transfected cells, and of Ulip6 in various rat tissues,
homogenates were prepared according to standard procedures and
separated by 10% SDS^PAGE followed by Western blotting [9]. Anti-
gen/antibody complexes were visualized using enhanced chemilumi-
nescence (Pierce) and Kodak Biomax ¢lm. Protein concentration
was measured by the method of Bradford [10] using bovine serum
albumin as a standard.
3. Results and discussion
3.1. Isolation of rat and human Ulip6 cDNAs and structure of
the deduced proteins
In an attempt to isolate proteins that interact with the neu-
ronal glycine transporter GlyT2 [5], we used the yeast two-
hybrid system to screen a rat brain cDNA library using the
large cytoplasmic N-terminal region of GlyT2 as a bait. This
identi¢ed a cDNA clone which contained an insert of 4821 bp.
The missing 5P region was completed by PCR (see Section 2);
this led to a 24 nucleotide extension of the original clone. The
protein sequence deduced from the complete cDNA of 4845
bp is shown in Fig. 1. The encoded protein displays highly
signi¢cant homologies to all known members of the unc-33
[11] like phosphoprotein (Ulip)/collapsin response mediator
protein (CRMP) family [12^19], and hence was termed Ulip6.
A BLAST search with the rat Ulip6 sequence identi¢ed
several homologous human ESTs (AI571188, N51749,
AA350414, AI498064, AI369696). Using primers correspond-
ing to the predicted non-coding regions of these human ESTs,
we isolated a cDNA of 1745 bp encoding the human Ulip6
protein. The deduced sequences of the human and rat proteins
show 97.7% identity and are composed of 564 amino acids
(calculated molecular weights in rat, 61.5 kDa; human, 61.4
kDa). Both proteins share homology values of 37% with the
Caenorhabditis elegans unc-33 protein. However, the Ulip6
Fig. 1. A: Primary structures of rat and human Ulip6. Asterisks and dots denote identical and homologous amino acid residues. The thin and
thick lines indicate peptide sequences used for immunization (anti-pep-1 and anti-pep-2, respectively). B: Phylogenetic tree of the unc-33 protein
family. The relationship between mammalian Ulip (m, mouse; r, rat; h, human) and C. elegans unc-33 protein sequences was analyzed by the
unweighted pair-group method-assisted (UPGMA) procedure [24] using GENETYX software.
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polypeptides are more homologous to the mammalian liver
enzyme dihydropyrimidinase (DHP or Ulip5) than to the neu-
ronal Ulip proteins 1^4 (Fig. 1B). An overall sequence identity
of 57% is found with Ulip5 (DHP) [17,18], whereas identities
of only 50^51% are seen with Ulip1^4 [12^16,19]. Homology
values di¡er signi¢cantly within the Ulip domains I^V postu-
lated by Byk et al. [19]. The most highly conserved region (90^
100% identity with the mammalian Ulip1^5) corresponds to
subdomain III dP, a 32 amino acid motif (residues 374^405 in
Ulip6) that is shared by two recently identi¢ed Ulip proteins
from C. elegans, the Pseudomonas putida bacterial hydantoi-
nase, Ulip5 (DHP) and the mammalian Ulip1^4 polypeptides
[19]. These latter proteins have been proposed to be part of
the signaling cascade that directs axon growth through guid-
ance molecules of the collapsin/semaphorin family [11,12].
3.2. Ulip6 mRNA and protein are highly expressed in the
embryonic and early postnatal nervous system
To unravel the site of expression of Ulip6, we examined the
distribution of the Ulip6 mRNA and protein in neuronal and
non-neuronal tissues. Of the latter, liver and kidney are
known to be primary sites of Ulip5 (DHP) expression. Fig.
2 shows a Northern blot analysis of Ulip6 transcript distribu-
tion. The blot probed with the coding region of the rat Ulip6
cDNA revealed a broad hybridizing band of 4.5^5.2 kb in
neuronal (brain cortex, cerebellum, spinal cord) but not
non-neuronal (heart, lung, liver, kidney) tissues. Notably, a
strong signal was only seen at embryonic day 18 (E18) and
the ¢rst day postnatally (P1), but not in adult nervous tissue.
The same mRNA was also detected when using a probe cor-
responding to the 3P non-coding region of the cDNA (data
not shown); its size is in excellent agreement with the size of
the full-length cDNA clone (4845 bp) isolated from rat. A
possible explanation for the di¡use nature of the Ulip6
mRNA may be the existence of multiple poly(A) addition
signals. An ATTAAA sequence, positioned at nucleotides
4825^4830, may be used in addition to an AATAAA tract
found at nucleotides 4412^4417 (Fig. 2B). Notably, a poly-
(GT) sequence is found about 60 bp 3P of the potential up-
stream polyadenylation site. Such GT-rich sequences have
been proposed to bind components of the transcriptional ma-
chinery, such as cleavage stimulation factors [20]. In conclu-
sion, the Ulip6 mRNA is predominantly expressed in embry-
onic and neonatal neuronal tissue, and its level is down-
regulated during postnatal development. Similar expression
patterns have also been described for the other neuronal
Ulip proteins, Ulip1^4 [13^16,19].
To further corroborate the selective expression of Ulip6 in
the developing rat brain, we raised speci¢c antibodies against
peptides deduced from amino acids 474^491 and 513^528 of
the rat and human proteins. Fig. 3A shows that the resulting
antibodies detected speci¢cally Ulip6, but not mouse Ulip1^4,
upon heterologous expression of the HA-tagged polypeptides
in HEK 293 cells. Thus, our antisera were highly selective for
Ulip6 (the lack of mouse Ulip1^4 immunoreactivities cannot
be attributed to the species di¡erence, since Ulip sequences
are s 99% conserved between rat and mouse). Using these
antibodies, we again detected Ulip6 only in neuronal tissues
including cortex, cerebellum and spinal cord. Also, protein
levels were high at E18 and P1, but dropped to very low levels
in the adult nervous system, thus corroborating our data on
mRNA distribution shown in Fig. 2A.
3.3. Conclusion
In this study, we describe a novel unc-33 related protein
from rat and human, named Ulip6. Its primary sequence is
most similar to Ulip5 (DHP) found in liver and kidney, but its
expression pattern characterized by high mRNA and protein
levels in di¡erentiating neuronal tissue resembles that of the
neuronal Ulip1^4. This suggests that Ulip6 may play an im-
portant role in axon growth and neuronal di¡erentiation, as
proposed for the Ulip1^4 proteins [12,19,21]. It should, how-
ever, be noted that the structural similarity between Ulip6 and
DHP (Ulip5) may be indicative of related functions. In other
words, Ulip6 might display DHP activity although no such
activity has been detected in brain homogenates using a stan-
dard DHP assay [22]. Also, Ulip5 (DHP) is known to be a
homo-oligomeric trimer in its native conformation [23],
whereas other Ulip proteins such as Ulip2 and Ulip3 have
been reported to form hetero-oligomers. Future studies should
show whether Ulip6 may hetero-oligomerize with one of the
Ulip1^4 proteins, and whether it indeed serves in intracellular
signalling processes that control axon growth and neuronal
di¡erentiation.
During submission of this manuscript, the rat Ulip6 se-
Fig. 2. A:Distribution of Ulip6 transcripts in various rat tissues.
Northern blotting was performed as described in Section 2. After
hybridization to the Ulip6 probe, rehybridization disclosed the
GAPDH mRNA as a loading control. Abbreviations are: E12,
whole embryo day 12; E18B, embryonic brain day 18; Cor, brain
cortex; Cere, cerebellum; SC, spinal cord; H, heart; Lu, lung; Li,
liver; Ki, kidney; P1, 1 day after birth. B: Partial 3P untranslated
sequence of the rat Ulip6 cDNA. The thick lines indicate the two
poly(A) addition signals. A unique GT-rich region found about 60
bp after the ¢rst polyadenylation site is also underlined.
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quence has also been reported in electronic form as ‘CRMP3-
associated molecule’ (CRAM) by Inatome et al. (J. Biol.
Chem., papers in press, 10.1074/jbc.M910126199). Notably,
the deduced CRAM protein sequence di¡ers from rat Ulip6
by lacking one of the two cysteine residues at positions 125/
126 that are highly conserved throughout the Ulip family.
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Fig. 3. Western blot analysis. A: Speci¢city of anti-peptide antibodies against Ulip6. Lysates of HEK 293 cell transfected with the indicated
constructs were used for Western blotting with the respective antibodies. Expression levels of each construct were monitored by reprobing the
membrane with an anti-HA antibody (lower left panel). B: Distribution of Ulip6 protein in various rat tissues. The labelling of lanes is as in
Fig. 2A; 5 Wg of protein was applied per lane. In case of anti-pep-1, the X-ray ¢lm shown in the lower right panel was exposed 30 times longer
than that in the upper right panel. The positions of molecular weight markers (in kDa) are indicated.
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